Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration

Parasitology Research

Volumn 98, Issue 3, 2006, Pages 244-249

  Bassissi, Firas ^a   Lespine, Anne ^a   Alvinerie, Michel ^a  

^a CEMAGREF   (France)

Author keywords

Formulation; Ivermectin; Liposomal; Pharmacokinetic; Rabbit

Indexed keywords

DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE POLY(ETHYLENEGLYCOL) 5000; IVERMECTIN; LIPOSOME; MACROLIDE; MULTILAMELLAR LIPOSOMAL VESICLE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG EXPOSURE; DRUG FORMULATION; DRUG SCREENING; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIPARASITIC AGENTS; AREA UNDER CURVE; DOSAGE FORMS; HALF-LIFE; INJECTIONS, SUBCUTANEOUS; IVERMECTIN; LIPOSOMES; MALE; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 32144444312     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-005-0073-z     Document Type: Article

References (36)

1. Allen TM, Hansen CB, Guo LS (1993) Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta 1150:9-16
2. Allen TM, Hansen CB, Daniel E, Lopes de Meneres DE (1995) Pharmacokinetics of long-circulating liposomes. Adv Drug Deliv Rev 16:267-284
3. Alvinerie M, Sutra JF, Badri M, Galtier P (1995) Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection. J Chromatogr B Biomed Appl 674:119-124
4. Alvinerie M, Escudero E, Sutra JF, Eeckhoutte C, Galtier P (1998) The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep. Vet Res 29:113-118
5. Baggot JD, McKellar QA (1994) The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. J Vet Pharmacol Ther 17:409-419
6. Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Melissen PM, van Vianen W, van Etten EW (1993) Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections. Eur J Clin Microbiol Infect Dis 12 (Suppl 1):S61-S67
7. Bassissi MF, Alvinerie M, Lespine A (2004a) Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans. Comp Biochem Physiol C Toxicol Pharmacol 138:437-444
8. Bassissi MF, Lespine A, Alvinerie M (2004b) Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration. Parasitol Res 94:188-192
9. Chiu SH, Sestokas E, Taub R, Buhs RP, Green M, Sestokas R, Vandenheuvel WJ, Arison BH, Jacob TA (1986) Metabolic disposition of ivermectin in tissues of cattle, sheep, and rats. Drug Metab Dispos 14:590-600
10. Clark SL, Crowley AJ, Schmidt PG, Donoghue AR, Piche CA (2004) Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic) acid microparticles in dogs. Am J Vet Res 65:752-757
11. de Melo AL, Silva-Barcellos NM, Demicheli C, Frezard F (2003) Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes. Int J Pharm 255:227-230
12. de Montigny P, Shim JS, Pivnichny JV (1990) Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent. J Pharm Biomed Anal 8:507-511
13. Dourmishev A, Serafimova D, Dourmishev L (1998) Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 11:247-251
14. Dvoroznakova E, Hrckova G, Boroskova Z, Velebny S, Dubinsky P (2004) Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol Int 53:315-325
15. Hennessy DR (1997) Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds. Vet Parasitol 72:367-382 (discussion 382-390)
16. Hennessy DR, Alvinerie MR (2002) Pharmacokinetics of the macrocyclic lactones: conventional wisdom and new paradigism. In: Vercruysse J, Rew RS (eds) Macrocyclic lactones and antiparasitic therapy. CABI, Wallingford, pp 203-213
17. Hrckova G, Velebny S, Corba J (1998) Effects of free and liposomized praziquantel on the surface morphology and motility of Mesocestoides vogae tetrathyridia (syn. M. corti; Cestoda: Cyclophyllidea) in vitro. Parasitol Res 84:230-238
18. Kim S (1993) Liposomes as carriers of cancer chemotherapy. Current status and future prospects. Drugs 46:618-638
19. Kurzchalia TV, Ward S (2003) Why do worms need cholesterol? Nat Cell Biol 5:684-688
20. Leak LV (1971) Studies on the permeability of lymphatic capillaries. J Cell Biol 50:300-323
21. Lespine A, Sutra JF, Dupuy J, Alvinerie M, Aumont G (2004) The influence of parasitism on the pharmacokinetics of moxidectin in lambs. Parasitol Res 93:121-126
22. Liu X, Sun Q, Wang H, Zhang L, Wang JY (2005) Microspheres of corn protein, zein, for an ivermectin drug delivery system. Biomaterials 26:109-115
23. Lo PK, Fink DW, Williams JB, Blodinger J (1985) Pharmacokinetic studies of ivermectin: effects of formulation. Vet Res Commun 9:251-268
24. Matyash V, Geier C, Henske A, Mukherjee S, Hirsh D, Thiele C, Grant B, Maxfield FR, Kurzchalia TV (2001) Distribution and transport of cholesterol in Caenorhabditis elegans. Mol Biol Cell 12:1725-1736
25. Mourao SC, Costa PI, Salgado HR, Gremiao MP (2005) Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes. Int J Pharm 295:157-162
26. Olson F, Hunt CA, Szoka FC, Vail WJ, Papahadjopoulos D (1979) Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta 557:9-23
27. Oussoren C, Storm G (2001) Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 50:143-156
28. Perez R, Cabezas I, Godoy C, Rubilar L, Munoz L, Arboix M, Castells G, Alvinerie M (2002) Pharmacokinetics of doramectin and ivermectin after oral administration in horses. Vet J 163:161-167
29. Rumjanek FD, Simpson AJ (1980) The incorporation and utilization of radiolabelled lipids by adult Schistosoma mansoni in vitro. Mol Biochem Parasitol 1:31-44
30. Satou T, Horiuchi A, Akao N, Koike K, Fujita K, Nikaido T (2005) Toxocara canis: search for a potential drug amongst beta-carboline alkaloids - in vitro and mouse studies. Exp Parasitol 110:134-139
31. Sovell JR, Holmes JC (1996) Efficacy of ivermectin against nematodes infecting field populations of snowshoe hares (Lepus americanus) in Yukon, Canada. J Wildl Dis 32:23-30
32. Tagboto SK, Townson S (1996) Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo. Ann Trop Med Parasitol 90:497-505
33. Wagner R, Wendlberger U (2000) Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites. Vet Parasitol 93:149-158
34. Wright FC, Riner JC (1985) Comparative efficacy of injection routes and doses of ivermectin against Psoroptes in rabbits. Am J Vet Res 46:752-754
35. Yamaoka K, Nakagawa T, Uno T (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 6:165-175
36. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879-885